1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Presence of viable gram-positive bacteria in blood of patients with inflammatory bowel disease is not affected by treatment
- Contribution to journal › Article
- 2024
-
Mark
Optimization of tools for monitoring, evaluating, and treating inflammatory conditions of the bowel
(2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
- 2023
-
Mark
Long-term outcomes of vedolizumab in inflammatory bowel disease : the Swedish prospective multicentre SVEAH extension study
- Contribution to journal › Article
-
Mark
CRP in Outpatients with Inflammatory Bowel Disease Is Linked to the Blood Microbiota
- Contribution to journal › Article
- 2021
-
Mark
Capturing biologic treatment for IBD in the Swedish Prescribed Drug Register and the Swedish National Patient Register–a validation study
- Contribution to journal › Article
-
Mark
Real-world effectiveness of vedolizumab in inflammatory bowel disease : week 52 results from the Swedish prospective multicentre SVEAH study
- Contribution to journal › Article
-
Mark
Adult-onset inflammatory bowel disease and rate of serious infections compared to the general population : a nationwide register-based cohort study 2002–2017
- Contribution to journal › Article
- 2020
-
Mark
Nomenclature and semantic descriptions of ulcerative and inflammatory lesions seen in Crohn’s disease in small bowel capsule endoscopy : An international Delphi consensus statement
- Contribution to journal › Article
- 2019
-
Mark
Marked regional variations in the prevalence of inflammatory bowel disease in a limited geographical region are not associated with compounds in the drinking water
- Contribution to journal › Article
- 2018
-
Mark
Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
- Contribution to journal › Article
